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ABSTRACT
tRNA damage inflicted by the Escherichia coli anti-
codon nuclease PrrC (EcoPrrC) underlies an antiviral
response to phage T4 infection. PrrC homologs
are present in many bacterial proteomes, though
their biological activities are uncharted. PrrCs
consist of two domains: an N-terminal NTPase
module related to the ABC family and a distinctive
C-terminal ribonuclease module. In this article, we
report that the expression of EcoPrrC in budding
yeast is fungicidal, signifying that PrrC is toxic in a
eukaryon in the absence of other bacterial or viral
proteins. Whereas Streptococcus PrrC is also toxic
in yeast, Neisseria and Xanthomonas PrrCs are not.
Via analysis of the effects of 118 mutations on
EcoPrrC toxicity in yeast, we identified 22 essential
residues in the NTPase domain and 11 in the
nuclease domain. Overexpressing PrrCs with muta-
tions in the NTPase active site ameliorated the
toxicity of wild-type EcoPrrC. Our findings support
a model in which EcoPrrC toxicity is contingent on
head-to-tail dimerization of the NTPase domains to
form two composite NTP phosphohydrolase
sites. Comparisons of EcoPrrC activity in a variety
of yeast genetic backgrounds, and the rescuing
effects of tRNA overexpression, implicate
tRNA
Lys(UUU) as a target of EcoPrrC toxicity in yeast.
INTRODUCTION
Transfer RNAs are essential components of the transla-
tion machinery; they are also vulnerable targets for bac-
terial and fungal endoribonuclease toxins (ribotoxins) that
incise speciﬁc tRNA anticodons and arrest cell growth.
Secreted tRNA ribotoxins, such as bacterial colicins D
and E5, Kluyveromyces lactis g-toxin and Pichia acaciae
toxin, provide a means to discriminate self from non-self
species and suppress growth of the latter (1–5).
Intracellular ribotoxins are normally maintained in a
latent state, but are activated in response to cellular
stress or viral infection (6–8).
The Escherichia coli PrrC anticodon nuclease (ACNase)
represents an RNA-based intracellular innate immune
system of host defense against a foreign invader (6).
PrrC is maintained in a latent state by association with
the host DNA restriction-modiﬁcation enzyme encoded by
the prrA, prrB and prrD ORFs of the E. coli prr operon
(9,10). The PrrC ACNase is activated by a virus-encoded
protein, Stp, synthesized early during bacteriophage T4
infection (11–13). Active PrrC incises tRNA
Lys at a
single site in the anticodon loop, 50 of the modiﬁed
wobble uridine (mnm
5s
2U), to generate a 20,30-cyclic phos-
phate and a 50-OH at the broken ends. Unopposed deple-
tion of tRNA
Lys interdicts synthesis of viral late proteins
and prevents spread of the virus through the population.
However, the phage thwarts the RNA-damaging host
defense by encoding an RNA repair system, consisting
of T4 polynucleotide kinase-phosphatase (Pnkp) and T4
RNA ligase 1 (Rnl1), that heals and seals the broken
tRNA ends (14). tRNA restriction as a defense mechanism
against phages is seemingly widespread in the bacterial
domain, insofar as: (i) PrrC homologs are present in
many diverse bacteria; and (ii) RNA repair enzymes are
encoded by viruses other than T4 (15).
E. coli PrrC (EcoPrrC) is the only member of the large
PrrC-like family for which a biological role (antiviral host
defense) and a speciﬁc RNA target have been deﬁned.
EcoPrrC is a 396-aa polypeptide composed of two
putative domains: an N-terminal nucleoside triphosphate
phosphohydrolase (NTPase) module (aa 1–264) related to
the ABC transporter family and a C-terminal ‘nuclease’
module (aa 265–396) that has no apparent similarity to
any known nuclease or tRNA-binding protein. Gabriel
Kaufmann’s laboratory has reported that: (i) active
EcoPrrC is a homo-oligomeric complex; (ii) EcoPrrC
nuclease activity is triggered by GTP hydrolysis and
activated allosterically by dTTP; (iii) tRNA
Lys is the
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is inﬂuenced by base modiﬁcations in the tRNA anticodon
loop (16–19).
Davidov and Kaufmann (20) recently identiﬁed
Geobacillus kaustophilus RloC (GkaRloC) as the
exemplar of a distinct subfamily of bacterial PrrC-like
ribotoxins, in which the NTPase domain contains a
large modular insert with a putative coiled-coil/
zinc-hook structure reminiscent of Rad50. GkaRloC
incises the anticodon loop of tRNA
Glu and to a lesser
extent tRNA
Lys, tRNA
Arg and tRNA
Gln, when expressed
in E. coli cells. In contrast to EcoPrrC, which merely nicks
the tRNA backbone, GkaRloC performs two nuclease re-
actions on either side of the wobble uridine of a tRNA
Lys
substrate, leaving 20,30-cyclic phosphate and 50-OH termini
at each cleavage site. The net result is excision of the
wobble nucleoside, which effectively precludes regener-
ation of a functional tRNA by a T4-like RNA-repair
system.
Biochemical and structural studies of EcoPrrC have
been hindered by the self-limiting capacity for expression
of active PrrC in bacteria (i.e. PrrC curtails bacterial
protein synthesis). Nonetheless, the Kaufmann laboratory
has identiﬁed several functionally important components
of the EcoPrrC protein, by surveying for mutations that
affect PrrC toxicity in E. coli or assaying ACNase activity
in extracts of E. coli expressing PrrC mutants (18,19,21).
We and others have exploited budding yeast
Saccharomyces cerevisiae as a surrogate system to study
the effects of intracellular expression of tRNA anticodon
nucleases, e.g. g-toxin, colicin D, colicin E5 (22–24). Here
we apply this strategy to EcoPrrC and PrrC homologs
from other bacteria. We ﬁnd that EcoPrrC is toxic to
yeast cells, as is Streptococcus mutans PrrC (SmuPrrC).
In contrast, the Neisseria meningitidis (Nme) and
Xanthomonas campestris (Xca) PrrCs are nontoxic. We
gained new insights to structure–function relationships
in the PrrC family via an extensive mutational analysis
of EcoPrrC. Comparisons of PrrC activity in a variety of
yeast genetic backgrounds implicate tRNA
Lys as a
relevant target of EcoPrrC toxicity in a eukaryon, as it is
in bacteria, notwithstanding the differences in the anti-
codon base-modiﬁcation proﬁles of eukaryal and bacterial
tRNA
Lys. We discuss possible therapeutic niches for en-
zymatic ribotoxins in eukarya.
MATERIALS AND METHODS
PrrC expression plasmids
The E. coli prrC gene was inserted into yeast plasmid
YCplac111 (CEN LEU2) under the transcriptional
control of a GAL1 promoter to yield pYC-EcoPrrC. The
amino acid sequence of the plasmid-encoded 396-aa
EcoPrrC polypeptide is shown in Figure 2A. Missense mu-
tations were introduced in the prrC gene in pYC-EcoPrrC
by two-stage overlap extension PCR with mutagenic
primers. The prrC ORF was sequenced in each case to
verify the intended coding change and exclude the acqui-
sition of unwanted coding changes during ampliﬁcation
and cloning. EcoRI/SalI fragments containing
GAL1-prrC-Ala expression cassettes were excised from
pYC-EcoPrrC-Ala and inserted into multicopy yeast
plasmid pRS423 (2m HIS3).
The genes encoding PrrC homologs from Neisseria
meningitidis (accession NP_273873), Streptococcus
mutans (accession NP_721301) and Xanthomonas
campestris (accession NP_635858) were ampliﬁed by
PCR from genomic DNAs obtained from ATCC. The
sense-strand PCR primers were designed to introduce an
NdeI site at the translation start codon. The antisense
primers introduced a SalI site downstream of the stop
codon. The PCR products were digested with NdeI and
SalI and inserted between the corresponding sites in
pYC-EcoPrrC in lieu of the EcoPrrC fragment.
Sequencing of the inserts in the resulting pYC-NmePrrC,
pYC-SmuPrrC and pYC-XcaPrrC plasmids veriﬁed that
no coding changes had been introduced during ampliﬁca-
tion and cloning.
tRNA expression plasmids
The 2m URA3 plasmids bearing the yeast genes for
tRNA
Glu(UUC), tRNA
Lys(UUU), tRNA
Gln(UUG),
tRNA
Arg(UCU), tRNA
Gly(UCC), tRNA
Leu(UAA) and
tRNA
Tyr(GUA) are described (25). A 2m URA3
tRNA
Lys(CUU) plasmid was constructed by PCR amplify-
ing a 1-kb fragment of S. cerevisiae chromosome III
genomic DNA containing this tRNA gene and inserting
it between BamHI and SalI sites in YEplac195 to generate
pLysCUU. A KpnI/BglII fragment containing the
tRNA
Lys(UUU) gene was then inserted between KpnI and
BamHI site of pLysCUU to generate pLysCUU/UUU
bearing both tRNA
Lys isoacceptors. The sequences of
the tRNA inserts were veriﬁed for each of the new con-
structs used in this study.
PrrC toxicity assays
The haploid S. cerevisiae strain W303 was used in all ex-
periments unless speciﬁed otherwise. The trm9 and
tot3 derivatives of W303 are described (25,26). Yeast
cells were transformed with plasmid DNAs by using the
lithium acetate method (27). Transformants were selected
on appropriate selective minimal synthetic media on 2%
(w/v) bacto agar plates.
Toxicity of the plasmid-encoded PrrC proteins was
gauged as follows. Cells derived from single transformants
were grown at 30 C in liquid culture in selective media
containing 2% glucose. The cultures were adjusted to
A600 of 0.1 and then diluted in water in serial 5-fold dec-
rements. Aliquots (3ml) of the dilutions were then spotted
in parallel on selective agar plates containing either 2%
glucose or 2% galactose. The plates were photographed
after incubation at 30 C for 2 (glucose) or 3days
(galactose).
Alternatively, the growth and viability of yeast cells
bearing CEN LEU2 PrrC plasmids were monitored in
liquid cultures as follows. Cells derived from single
transformants were grown overnight at 30 C in SD–Leu
medium containing 2% rafﬁnose. The cultures were
adjusted to A600 of 0.1 by dilution into –Leu media con-
taining either 2% glucose or 2% galactose (time 0). The
688 Nucleic Acids Research, 2011,Vol. 39,No. 2cultures were then incubated at 30 C with constant
shaking and A600 was monitored at 3-h intervals. Viable
cell counts were determined by withdrawing aliquots at 3 h
intervals, diluting them 1:50 in water, and then plating 10,
100 and 250ml of this sample on SD–Leu agar plates con-
taining 2% glucose. Colonies were counted after incuba-
tion for 2days at 30 C.
Dominant negative effects of PrrC-Ala mutants
Yeast cells were cotransformed with pYC-EcoPrrC (CEN
LEU2) or the empty CEN vector and each of 15
pRS-EcoPrrC-Ala plasmids (2m HIS3) encoding
nontoxic EcoPrrC mutants or the empty 2mvector. Cells
derived from single transformants were grown at 30 Ci n
liquid culture in SD–Leu–His medium containing 2%
glucose. The cultures were adjusted to A600 of 0.1 and
then diluted in water in serial 5-fold decrements.
Aliquots (3ml) of the dilutions were then spotted in
parallel on –Leu–His agar plates containing either 2%
glucose or 2% galactose. The plates were photographed
after incubation at 30 C for 2 (glucose) or 3days (galact-
ose). Alternatively, the growth of yeast cells bearing
pYC-EcoPrrC and pRS-EcoPrrC-Ala (or empty vector
controls) was monitored in liquid cultures. Cells derived
from single transformants were grown at 30 C in SD–
Leu–His medium containing 2% rafﬁnose until A600
reached  2. Aliquots of the cultures were then diluted
with SD–Leu–His medium containing 2% galactose to
an A600 of 0.1. The cultures were incubated at 30 C with
constant shaking for 18h, at which time A600 was
measured.
RESULTS AND DISCUSSION
Induced expression of E. coli PrrC in budding yeast is
toxic
We installed the E. coli prrC gene in yeast on a CEN
plasmid under the control of a glucose-repressed/
galactose-induced GAL1 promoter. Galactose induction
of PrrC production suppressed yeast growth on agar
medium (Figure 1A) and in liquid culture (Figure 1B).
By analyzing yeast survival after transient galactose induc-
tion and return to glucose, we found that PrrC expression
was profoundly fungicidal (Figure 1C). The number of
viable cells in the yeast culture decreased by 19-fold
within 3h of EcoPrrC induction, by 350-fold after 9h
and by 550-fold after 12h (Figure 1C). Control experi-
ments veriﬁed that CEN prrC yeast cells grew as well as
cells bearing the empty CEN vector on glucose-containing
agar and liquid media (Figure 1A and B). These results
showed that EcoPrrC is an effective toxin in a eukaryal
cell, in the absence of any other bacterial or bacteriophage
proteins, including the DNA restriction enzyme with
Figure 1. Induced expression of EcoPrrC and SmuPrrC is toxic to S. cerevisiae. (A) Serial 5-fold dilutions of yeast cells bearing a CEN plasmid
encoding the indicated galactose-regulated prrC gene or an empty CEN vector were spotted on –Leu agar plates containing 2% glucose or galactose
as speciﬁed. (B) Growth of liquid cultures of yeast cells bearing EcoPrrC or SmuPrrC plasmids or the empty vector was monitored by determining
A600 at serial times after transfer from rafﬁnose medium to media containing glucose or galactose. Each datum is the average of three independent
growth experiments ±SEM. (C) Viable cell counts of liquid cultures of yeast cells bearing a EcoPrrC or SmuPrrC plasmid were determined
immediately prior to (time 0) and at serial 3-h intervals after galactose induction, by plating aliquots on –Leu agar containing 2% glucose. Each
datum is the average of three independent galactose-induction experiments ±SEM.
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triggers PrrC activity during virus infection.
Remarkably, not all bacterial PrrCs are created equal in
this respect. Nme- and XcaPrrC were nontoxic in yeast,
while SmuPrrC was toxic (Figure 1A). Like EcoPrrC,
SmuPrrC arrested yeast growth in liquid medium
(Figure 1B) and was fungicidal after transient galactose
induction and return to glucose (Figure 1C). We infer
from these results that the toxic Eco and Smu PrrC
proteins can incise essential target RNAs in yeast cells.
The failure of NmePrrC to arrest yeast growth was
surprising to us, insofar as the nontoxic NmePrrC
protein has a signiﬁcantly higher degree of amino acid
identity (57%) with the EcoPrrC polypeptide than does
SmuPrrC (42%). It is conceivable that: (i) NmePrrC and
XcaPrrC are nontoxic in yeast because they lack RNase
activity, or (ii) NmePrrC and XcaPrrC are bona ﬁde
ribotoxins, but their targets are not present in budding
yeast (or are present but not essential for yeast growth).
With respect to the latter issue, we tested the effects of
induced expression of the four PrrCs on the growth
of E. coli and found that the results were concordant
those observed in yeast. Namely, EcoPrrC and SmuPrrC
were toxic to E. coli, whereas NmePrrC and XcaPrrC were
not (data not shown). Thus, it is not simply a matter of the
eukaryal milieu that masks an underlying ribotoxin
activity of NmePrrC and XcaPrrC. We surmise that
members of the PrrC family differ with respect to their
biological activity, which could reﬂect distinctive RNA
target speciﬁcities and/or reliance on unique coactivators,
e.g. if NmePrrC and XcaPrrC require additional proteins
from the cognate bacterium to manifest their RNase
functions.
Structure-function analysis of EcoPrrC by
alanine-scanning
The toxicity elicited by EcoPrrC expression in yeast
affords a convenient assay to probe structure-activity re-
lations. Our aim in this study was to map the amino acid
functional groups of EcoPrrC required for cytotoxicity via
alanine-scanning guided by a primary structure alignment
of the Eco, Nme and Smu PrrC proteins (Figure 2A). We
tested 53 EcoPrrC-Ala mutants for galactose-induced
toxicity (Table 1). We thereby identiﬁed 20 nonessential
residues (colored yellow in Figure 2A) and 33 essential
residues (colored green in Figure 2A). In the case of
nonessential residues such as His23, Lys238 and Lys325,
their replacement by alanine still allowed for virtually
complete growth inhibition on galactose-containing
medium (Figure 2B). The EcoPrrC-C386A mutant also
retained cytoxicity, albeit with very faint growth of the
expressing yeast cells on galactose agar (Figure 2B), sug-
gesting that C386A might be a hypomorph (see below.)
Essential PrrC residues were those—like His295, Arg320,
Arg349 and His356 in the C-terminal domain—at which
alanine changes eliminated toxicity and permitted growth
on galactose that was similar to that of the vector control
(Figure 2B). Among the essential residues in the
N-terminal domain were the ﬁve PrrC counterparts
(Lys46, Thr47, Asp215, Asp216 and His251) of the
constituents of the conserved NTP-binding site of the
ABC transporter NTPases (28). We infer that NTP
binding/hydrolysis is essential for EcoPrrC toxicity in
yeast. The collection of 33 essential PrrC residues (22 in
the N-domain and 11 in the C-domain) included six histi-
dines, ﬁve lysines, three arginines, six aspartates, ﬁve as-
paragines, three glutamates, two threonines, two serines
and a tryptophan (Table 1).
Structure–activity relationships at essential residues in the
NTPase domain
We proceeded to determine structure–activity relation-
ships for each of the 22 essential residues in the NTPase
domain by testing the effects of 43 conservative sub-
stitutions. The results are summarized in Table 1 and
discussed below, wherever possible, in light of structures
of the homologous motor domains of ABC-family
NTPases bound to nucleotide and a divalent cation
cofactor (28–31).
The PrrC NTPase domain contains a consensus Walker
A-box motif (AxxGxGKT
47) found in many
nucleotide-dependent phosphotransferases. The A-box is
situated between the ﬁrst b-strand and the ﬁrst a-helix of
the NTPase module and forms a classical P-loop structure
in which the main-chain amide nitrogens and the signature
lysine side chain (Lys46 in PrrC) coordinate the NTP
phosphate oxygens (Supplementary Figure S1). The signa-
ture threonine/serine side chain vicinal to the lysine (Thr47
in PrrC) coordinates the divalent cation cofactor
that bridges the b and g phosphates (Supplementary
Figure S1). Lys46 and Thr47 were both essential for
PrrC toxicity, according to the alanine scan. Lys46 was
strictly essential, insofar as neither arginine nor glutamine
was active in its stead. Thr47 was also strictly essential;
neither serine not valine could sustain EcoPrrC toxicity in
yeast, implying that, in addition to the imputed coordin-
ation of magnesium by Thr-Og, the Thr47-Cg makes an
important contact as well. [In the case of human CFTR
ABC protein (pdb 2PZE; 31), the equivalent A-box threo-
nine makes a close van der Waals contact to the
metal-binding aspartate of the Walker B-box.] The
EcoPrrC Arg48 side chain ﬂanking the A-box was also
strictly essential for toxicity in yeast; neither lysine nor
glutamine was functional. It is possible that Arg48
engages in bidentate hydrogen bonding or ionic inter-
actions that lysine does not sustain. Arg48 is conserved
in NmePrrC and SmuPrrC, but is replaced by glutamine
in XcaPrrC (Figure 2A).
The ABC proteins are homodimers, arranged
head-to-tail, with two composite NTPase active sites
formed by motifs derived from the cis protomer (which
provides the A-box and B-box) and the trans protomer,
which interacts with the P-loop of the cis protomer and
also directly coordinates the NTP g phosphate
(Supplementary Figure S1). The EcoPrrC peptide
segment
215DDPVSSLDDNH
225, which embraces eight
essential side chains, is composed of two distinct ABC
motifs that form the active site: a Walker B-box
(YVFIDD
216) derived from the cis protomer and a ‘D
loop’ motif (SSLD
222 in EcoPrrC) derived from the
690 Nucleic Acids Research, 2011,Vol. 39,No. 2Figure 2. Homology-guided alanine-scanning mutagenesis of EcoPrrC. (A) The amino acid sequence of EcoPrrC is aligned to sequences of the
NmePrrC, SmuPrrC, and XcaPrrC proteins. Positions of side-chain identify/similarity in all four proteins are indicated by a ﬁlled black circle above
the alignment. The conserved peptide motifs of the N-terminal NTPase domain are demarcated by brackets. The 54 amino acids targeted in the
alanine scan are highlighted. Residues deﬁned as essential for yeast toxicity by the alanine scan are shaded green; nonessential residues are shaded
yellow. (B) Exemplary toxicity tests for wild-type EcoPrrC and EcoPrrC-Ala mutants are shown, in which serial 5-fold dilutions of yeast cells bearing
the indicated CEN GAL1-prrC plasmid were spotted on –Leu agar plates containing 2% glucose or galactose as speciﬁed.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 691trans protomer (Supplementary Figure S1). The B-box
provides two key carboxylates to the phosphohydrolase
active site. The proximal aspartate is a component of the
metal coordination complex. The vicinal Asp/Glu coord-
inates the water nucleophile. The corresponding Asp215
and Asp216 residues in EcoPrrC were both strictly essen-
tial; neither could be functionally substituted with aspara-
gine or glutamate, signifying that a carboxylate is essential
at both positions and that the putative PrrC active site
cannot accommodate the longer main-chain to the carb-
oxylate linker of Glu versus Asp.
In the ABC family, the eponymous aspartate side chain
of the D loop caps an a-helix and makes a cross-protomer
hydrogen bond with a phosphate-binding main chain
amide of the A-box (Supplementary Figure S1). We ﬁnd
that the D loop Asp222 residue of EcoPrrC was essential
and irreplaceable by Asn or Glu (Table 1). The two serines
preceding the D loop aspartate were both essential for
PrrC toxicity, but they displayed different
structure-activity relations. Toxicity was restored when
Ser219 was replaced by threonine or cysteine, signifying
that hydrogen bonding of the Og atom is the functionally
relevant property at this position and the extra methyl
group of threonine is benign. The equivalent D loop
serine in ABC proteins Sav1866 and HylB donates a
hydrogen bond to the main-chain carbonyl of the essential
B-box acidic residue located three residues upstream (cor-
responding to EcoPrrC Asp216) (30,31) (Supplementary
Figure S1). We surmise that PrrC Ser219 plays a structural
role in stabilizing the conformation of the loop that
contains the contiguous B and D motifs. At Ser220 of
EcoPrrC, the S220T and S220C mutants were inactive
in vivo (Table 1), which suggests a tight steric constraint
on the Ser220 side chain that does not tolerate the extra
bulk of the threonine-Cg or even the larger atomic radius
of the cysteine-Sg versus serine-Og. The essential Asp223,
Asn224 and His225 residues ﬂanking the EcoPrrC D loop
are not generally conserved among ABC proteins. We
conclude that the carboxylate functional group is the per-
tinent property at position 223, because the D223E
mutant was toxic in yeast while D223N was nontoxic
(Table 1). Asp223 is conserved as Asp/Glu in the Smu,
Nme and Xca PrrCs (Figure 2A). At Asn224, the amide
group was critical for function, i.e. glutamine restored
toxicity while aspartate did not. At His225, asparagine
supported PrrC activity though glutamine did not, which
suggests that hydrogen bonding by His225-Nd is the
relevant property of this residue.
The KFIITTH
251 motif of EcoPrrC that spans three
essential side chains is the counterpart of the conserved
‘H loop’ motif of ABC-type NTPases (also called the
‘switch’ motif). The H loop connects a b-strand to an
a-helix. The signature histidine donates a hydrogen bond
to an NTP g phosphate oxygen (28) that would stabilize
the phosphohydrolase transition state. The H loop His251
of EcoPrrC is strictly essential for its activity in vivo,
Table 1. Mutational effects on PrrC ribotoxin activity in yeast
PrrC allele Toxicity PrrC allele Toxicity PrrC allele Toxicity PrrC allele Toxicity
WT + + E162A + + K238A + + H315A –
H23A + + K168A – K245A – H315N –
K46A – K168R – K245R + + H315Q –
K46R – K168Q – K245Q – R320A –
K46Q – K171A – T250A – R320K –
T47A – K171R + + T250S – R320Q –
T47S – K171Q – H251A – N321A –
T47V – H204A + + H251N – N321Q –
R48A – D215A – H251Q – N321D –
R48K – D215E – N257A – E324A –
R48Q – D215N – N257Q + + E324D –
D68A + + D216A – N257D – E324Q –
E69A + + D216E – E262A – K325A + +
E71A + + D216N – E262Q – R349A –
E88A – S219A – E262D + + R349K –
E88D – S219T + + C268A + + R349Q –
E88Q + + S219C + + D276A – N352A –
D89A + + S220A – D276N – N352D –
W93A – S220T – D276E – N352Q + +
W93Y – S220C – S291A + + S355A + +
W93H – D222A – S293A + + H356A –
D94A – D222E – H295A – H356N –
D94E – D222N – H295N – H356Q –
D94N – D223A – H295Q – N385A + +
N95A – D223E + + H297A – C386A + +
N95Q – D223N – H297N –
N95D – N224A – H297Q –
D96A + + N224Q + + K299A –
E99A + + N224D – K299R –
D100A + + H225A – K299Q –
H144A + + H225N + +
D161A + + H225Q –
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(Table 1). The vicinal threonine-Og (corresponding to
Thr250 in PrrC) makes a hydrogen bond to the
main-chain amide of the H loop residue on the carboxyl
side of the histidine (28) and thereby stabilizes the loop
conformation. Loss of toxicity of the T250S mutant
indicated that threonine is strictly essential in this
position. The upstream Lys245 is essential for EcoPrrC
and conserved in other PrrC homologs (albeit not in
other ABC proteins). Positive charge appeared to sufﬁce
at this position, because K245R was active in yeast
whereas K245Q was not (Table 1). Two important
residues downstream of the H loop in EcoPrrC, Asn257
and Glu262, are conserved in NmePrrC and SmuPrrC, but
not in XcaPrrC or ABC proteins generally. The amide
group of Asn257 is the key property, because mutant
N257Q was toxic in yeast, whereas N257D was inactive
(Table 1). At Glu262, the carboxylate was critical, i.e.
E262D was toxic while E262Q was not. The C loop
motif of ABC proteins (also called the ABC-signature
motif) is conserved in EcoPrrC as LSKGE
173
(Figure 2A). A C loop derived from the trans protomer
packs closely against the nucleoside and g phosphate of
the NTP substrate. The C loop and the A box P-loop of
the cis protomer together form an oxyanion hole for the
NTP g phosphate (Supplementary Figure S1). Here we
found that Lys171 within the C loop and Lys168 immedi-
ately preceding the loop were both essential for EcoPrrC
toxicity. These two lysine residues are conserved among
the PrrC homologs (Figure 2A), but they displayed differ-
ent structure–activity relations. Whereas Lys168 was
strictly essential (i.e. arginine and glutamine rendered
PrrC nontoxic), Lys171 could be replaced functionally
by arginine, but not glutamine, signifying that positive
charge sufﬁced for activity at this position. The ABC
protein Sav1866 has a lysine at the position corresponding
to Lys168 in PrrC; the Sav1866 structure shows that the
lysine packs over the adenine base of the bound NTP, with
which it makes multiple van der Waals contacts (31; pdb
2ONJ).
Finally, we identiﬁed four essential residues (Glu88,
Trp93, Asp94 and Asn95) within the EcoPrrC segment
82YYNAFYEDLFYWDND
96 of the NTPase domain
that has been dubbed the ‘PrrC box’ by the Kaufmann
laboratory (19) in light of its strong conservation among
bacterial PrrC homologs (Figure 2A). There is little
primary structure similarity between the PrrC box and
the corresponding segments of ABC proteins, though it
is possible that the PrrC box is a divergent analog of the
ABC Q-loop motif. The Q loop is a mobile hinge that is
sensitive to the presence of NTP and metal ligands. The
eponymous glutamine side chain of the Q loop (e.g. Gln90
in the MJ0796 protein) makes direct contacts with metal
and the nucleophilic water in the phosphohydrolase active
site (28). Replacing PrrC box residue Glu88 with glutam-
ine supported toxicity in yeast, whereas aspartate did not.
This result signiﬁes that hydrogen bonding, not negative
charge, is the key property of this residue and that the
distance from the main-chain to the terminal functional
group of Glu/Gln is critical, accounting for why retraction
of this distance in aspartate leads to loss of PrrC activity.
Trp93 appeared to be strictly essential, in that function
was not revived by installation of alternative aromatic
(tyrosine) or planar hydrogen bonding (histidine)
residues (Table 1). The ﬂanking Asp94 and Asn95
residues were also strictly essential, i.e. the respective con-
servative mutants D94E, D94N, N95Q and N95D were
nontoxic (Table 1).
Structure–activity relationships at essential residues in the
nuclease domain
The C-terminal nuclease domains of PrrC and RloC
proteins have no discernible primary structure similarity
to any other tRNA ribotoxins, or to any known ribonucle-
ases, phosphotransferases or tRNA-binding proteins. The
Kaufmann laboratory has proposed two functional com-
ponents of the EcoPrrC nuclease domain: (i) a triad
comprising Arg320, Glu324 and His356 that they impli-
cate in chemical catalysis of transesteriﬁcation at the
wobble nucleotide to generate 20,30-cyclic phosphate and
50-OH product strands (19); and (ii) a putative lysine anti-
codon recognizing peptide (LARP) motif,
284KYGDSNKSFSY
294 (33). The Arg–Glu–His triad is
conserved among PrrC and RloC homologs, consistent
with a catalytic function. In contrast, the LARP motif,
mutations of which affect the tRNA substrate preference
of EcoPrrC (16,17), is found only in a subset of PrrC
proteins and is absent from RloC (20,33). Thus it is con-
ceivable that LARP is a bona ﬁde determinant of the target
speciﬁcity of a subset of PrrC proteins that contains this
motif. However, LARP is unlikely be the decisive factor
with respect to yeast toxicity of bacterial PrrCs, insofar as
the EcoPrrC LARP is well conserved (10/11 identical
residues) in NmePrrC, which is not toxic in yeast, yet
LARP is not conserved (3/11 identical residues) in
SmuPrrC, which is toxic in yeast (Figure 2A). Two
alanine mutations in the EcoPrrC LARP motif tested pres-
ently (at Ser291 and Ser293, which are conserved in
NmePrrC) had no effect on cytotoxicity in yeast.
In mutagenizing the nuclease domain, we adopted an
agnostic view and mainly targeted residues we deemed
most likely to be involved in catalysis of phosphoryl
transfer (histidine, lysine, arginine, glutamate) or RNA
binding (lysine, arginine), based on general principles
and the speciﬁc mechanisms of other well-studied ribo-
nucleases that generate 20,30-cyclic phosphodiesters: e.g.
RNase A, RNase T1, colicin E5 and tRNA splicing endo-
nuclease (34–37). Our alanine scan identiﬁed 11 essential
amino acids in the nuclease domain, at which we assessed
structure-activity relationships with 22 conservative muta-
tions. The results are summarized in Table 1 and discussed
below in light of the catalytic mechanisms and structures
of analogous ribonucleases that leave 20,30-cyclic phos-
phate and 50-OH ends.
The ‘classical’ mechanism of RNA cleavage by
transesteriﬁcation exempliﬁed in RNase A relies on two
histidine side chains that serve, respectively, as: (i) a
general base catalyst that abstracts a proton from the at-
tacking ribose 20-OH, and (ii) a general acid catalyst that
donates a proton to the ribose 50-OH leaving group (34).
We replaced His295, His297, His315 and His356 in the
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paragine and found that each histidine was strictly essen-
tial for toxicity (Table 1). Three of them—His295, His315
and His356—are conserved among PrrC homologs, and
are therefore plausible candidates for a catalytic role,
possibly as acid–base catalysts. Two of these three histi-
dines (His295 and His356) are also conserved in RloC
(20). In contrast, His297, though retained as histidine in
nontoxic NmePrrC, is replaced by methionine in the toxic
SmuPrrC protein (Figure 2A), a scenario that makes it
unlikely that His297 acts as a general acid–base catalyst.
Structural and functional studies of RNase A highlight
a single essential lysine that interacts with the scissile
phosphodiester and stabilizes the pentacoordinate transi-
tion state (34). None of the nine lysines in the nuclease
domain of EcoPrrC is conserved in all three of the other
PrrC homologs aligned in Figure 2A. Of the two lysines
that we chose for the alanine scan, Lys325 was unessential
and Lys299 was essential. PrrC was nontoxic when Lys299
was replaced conservatively by arginine or glutamine
(Table 1). Yet, because this lysine is replaced by a valine
and leucine in SmuPrrC and XcaPrrC, we think it unlikely
that Lys299 plays a direct catalytic role in EcoPrrC.
Arginines classically play a role in ground-state binding
and transition-state stabilization during phosphoryl
transfer reactions by making bidentate contacts to the
phosphate oxygens. Several of the transesterifying ribo-
nucleases with known structures assimilate a catalytic
arginine in their active sites. For example, the colicin E5
active site includes an arginine that coordinates both
nonbridging oxygens of the scissile phosphodiester (37).
The active site of RNase T1 also has an arginine that
contacts the scissile phosphodiester (38). The active site
of barnase includes two arginines that contact the
scissile phosphodiester (39). Here we identiﬁed two argin-
ines in the nuclease domain (Arg320 and Arg349) as
strictly essential for EcoPrrC toxicity, i.e. Ala, Lys and
Gln mutants thereof were inactive (Table 1). Both of
these arginines are conserved in the toxic SmuPrrC
homolog (Figure 2A) and in RloC (18) and are therefore
plausible candidates for a catalytic role.
Glu324 was strictly essential for EcoPrrC toxicity
(Table 1). This position is conserved as glutamate in the
Nme, Smu and Xca homologs (Figure 2A) and also in
RloC. Glutamate acts as a general base catalyst of RNA
transesteriﬁcation by RNase T1 and barnase (35,39,40).
We identiﬁed two essential asparagines in the EcoPrrC
nuclease domain. Asn321 was strictly essential (Ala, Gln
and Asp mutants were inactive; Table 1). This residue
is conserved as Asn or Gln among PrrC homologs
(Figure 2A). At Asn352, the Ala and Asp changes
eliminated toxicity, but the conservative N352Q mutant
retained toxicity. This result attests to the importance of
the amide functional group at position 352 and tolerance
by EcoPrrC of the longer main-chain to amide distance in
Gln versus Asn. Asn352 is conserved as Asn in PrrC
homologs (Figure 2A) and in RloC (18).
In sum, our mutational study of the nuclease domain
veriﬁes the importance of several residues studied by
Kaufmann and colleagues (19), while identifying new can-
didate constituents of the active site and establishing
structure–activity relationships for each of 11 essential
residues. A deﬁnitive interpretation of the mutational
data awaits an atomic structure of the nuclease domain.
EcoPrrC is toxic in the absence of a modiﬁed tRNA
mcm
5U wobble base
The target speciﬁcity of many tRNA anticodon nucleases
is achieved via recognition of modiﬁed nucleobases in the
anticodon loop, especially the wobble base. For example,
colicin E5 cleaves bacterial tRNA
Tyr, tRNA
His, tRNA
Asn
and tRNA
Asp that contain the wobble base queosine (37).
K. lactis g-toxin speciﬁcally cleaves yeast tRNA
Glu(UUC)
containing the modiﬁed wobble base mcm
5s
2U
(5-methoxycarbonylmethyl-2-thiouridine; Figure 3C)
(3,4). Pichia acaciae toxin (PaT) exerts its toxicity by
incising a different yeast tRNA containing the mcm
5s
2U
wobble base: tRNA
Gln(UUG) (5).
EcoPrrC incises bacterial tRNA
Lys(UUU) at a single
phosphodiester 50 of the modiﬁed wobble base mnm
5s
2U
(5-methylaminomethyl-2-thiouridine) (16) (Figure 3C).
The mnm
5U wobble modiﬁcation does not exist in
eukaryal tRNAs, which instead have mcm
5s
2U in their
tRNA
Lys(UUU) (and also in tRNA
Glu and tRNA
Gln).
Kluyveromyces lactis g-toxin requires the mcm
5s
2U modi-
ﬁcation in its tRNA
Glu target, such that yeast
tot3(elp3)and trm9 mutants, which either fail to
modify the C5 atom or fail to add the terminal methyl
group (Figure 3C), are resistant to g-toxin’s effects (41).
Consequently, galactose-induced intracellular expression
of g-toxin, which prevents growth of wild-type S.
cerevisiae, had no effect on the growth of tot3 and
trm9 cells (Figure 3A). In contrast, we found that
EcoPrrC was toxic to tot3 and trm9 cells
(Figure 3A). Thus, we infer that: (i) the target speciﬁcity
of PrrC in yeast differs from that of g-toxin; and (ii) if
PrrC exerts its toxicity in yeast by cleaving tRNA
Lys, then
it does so without strict need for the mcm
5s
2U wobble
modiﬁcation.
Is yeast tRNA
Lys a target of EcoPrrC?
If an intracellular ribotoxin exerts its effect by breaking a
speciﬁc cellular RNA target, then one might expect to
reverse the toxicity by overexpressing the RNA target.
This is demonstrated nicely for K. lactis g-toxin,
whereby overexpression of its speciﬁc target
tRNA
Glu(UUC) protects yeast from toxin-induced growth
arrest (25) (Figure 3B). Here we screened various yeast
tRNAs on multicopy 2m plasmids for their ability to
protect yeast from the toxicity of EcoPrrC. Increased
gene dosage of tRNA
Glu(UUC) afforded no protection
from EcoPrrC, but neither did overexpression of the pre-
sumptive target tRNA
Lys(UUU), the isoacceptor
tRNA
Lys(CUU) or a combination of both tRNA
Lys(UUU)
and tRNA
Lys(CUU) (Figure 3B). High-copy plasmids
expressing other tRNAs with wobble uridines (tRNA
Gln,
tRNA
Arg, tRNA
Leu or tRNA
Gly) or tRNA
Tyr(GUA) were
also ineffective (data not shown). Several possibilities
come to mind to explain the negative results of the
tRNA rescue experiment: (i) tRNA
Lys is not a PrrC
target in yeast; (ii) tRNA
Lys is a PrrC target, but so are
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Lys is the princi-
pal PrrC target, but the level of anticodon nuclease
activity in the PrrC-producing yeast cells is sufﬁcient to
cleave the target tRNA pool even when the tRNA gene is
present in high copy.
To interrogate the third option, we surveyed several of
our collection of ‘active’ PrrC mutants for rescue of
toxicity by increased tRNA
Lys gene dosage. We focused
especially on two possibly hypomorphic mutants, C386A
and S219T, that were clearly toxic, but reliably yielded
faint spots when cells bearing the CEN prrC-C386A and
prrC-S219T plasmids were plated on galactose agar at low
dilution. We found that overexpression of tRNA
Lys(UUU)
partially protected yeast cells from the toxic effect of both
of these PrrC mutants, whereas overexpression of
tRNA
Lys(CUU) or tRNA
Glu(UUC) did not (Figure 4A).
This instructive result indicated that tRNA
Lys(UUU) is a
physiologic target of PrrC toxicity in yeast, as it is in
E. coli.
The inferred hypomorphic quality of EcoPrrC S219T
and C386A was reinforced by the results of experiment
shown in Figure 4B, wherein we analyzed their effect
on growth of trm9 cells. Whereas wild-type EcoPrrC
was profoundly toxic in trm9, neither of the mutants
Figure 3. EcoPrrC is toxic in the absence of a modiﬁed tRNA mcm
5U wobble base. (A) Serial 5-fold dilutions of wild-type (WT), trm9, and tot3
yeast cells bearing a CEN plasmid encoding galactose-regulated EcoPrrC or K. lactis g-toxin were spotted on –Leu agar plates containing 2% glucose
or galactose as speciﬁed. (B) Serial dilutions of wild-type yeast cells bearing a CEN plasmid encoding galactose-regulated EcoPrrC or K. lactis g-toxin
plus a 2m plasmid carrying the indicated yeast tRNA genes were spotted on –Leu–Ura agar plates containing glucose or galactose. (C) Structures of
the wobble uridine modiﬁcations found in tRNA
Lys(UUU) of E. coli (mnm
5s
2U), wild-type yeast (mcm
5s
2U) and yeast mutants trm9 (cm
5s
2U;
5-carboxymethyl-2-thiouridine) and tot3 (s
2U; 2-thiouridine).
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they had a modest effect on growth rate, as gauged by
colony size compared to the vector control (Figure 4B).
Moreover, while the toxicity of wild-type EcoPrrC in
trm9 cells was unabated by increased dosage of
tRNA
Lys, the same maneuver sufﬁced to reverse the
slow-growth phenotypes of the S219T and C386A
mutants (Figure 4B). In contrast, the yeast tot3
mutation per se afforded no protection against the toxic
effect of the S219T mutant, and only minimally protection
against C386A (evident at low dilution), notwithstanding
that partial protection of tot3 cells against both mutants
was still conferred by tRNA
Lys overexpression
(Figure 4C).
We surmise from these experiments that: (i) EcoPrrC
can target a wobble uridine with either bacterial mnm
5
or eukaryal mcm
5 modiﬁcations in vivo; and (ii) EcoPrrC
can also target a wobble uridine with no modiﬁcations at
the C5 atom (tot3). However, an incompletely modiﬁed
eukaryal wobble uridine lacking the terminal methyl
group (trm9; Figure 3C) is relatively resistant in vivo to
EcoPrrC S219T and C386A. Our ﬁndings resonate with
in vitro studies from the Kaufmann laboratory (16,17) that
showed a hierarchy of wobble base-modiﬁcation effects on
the cleavage of anticodon stem-loop structures by extracts
of E. coli expressing a different hypomorphic EcoPrrC
mutant (D222E). The order of wobble U preferences
was: mnm
5s
2U>s
2U>mcm
5s
2U.
Dominant negative effects of PrrC mutants
PrrC and RloC are the only known ribotoxins with an
ABC-like NTPase domain. Whereas the present mutation-
al scan of the EcoPrrC NTPase fortiﬁed the conclusion
that NTP binding and/or hydrolysis are essential for
PrrC toxicity, the mechanism by which the PrrC NTPase
activates the PrrC nuclease is unknown. It has been sug-
gested that one role of NTPase domain could be the regu-
lation the nuclease-masking interaction PrrC with the
EcoPrrI DNA restriction enzyme (18). This would not
be a factor in yeast toxicity studied presently. Structural
studies of other ABC domains highlight the general theme
that formation or stability of the head-to-tail ABC dimer
is inﬂuenced by NTP occupancy of the phosphohydrolase
active site. If it is true for PrrC that NTP binding acts as
an allosteric switch, then the key issue is whether the NTP
switch activates the nuclease directly (by inducing an
active state of the inherently latent nuclease domain) or
indirectly (by relieving the constitutively repressive effects
of the NTPase domain on an inherently competent
nuclease domain).
One prediction of a purely anti-repression model is that
removal of the NTPase domain might lead to a constitu-
tively active nuclease. However, this was not the case in
yeast, insofar as we found that induced expression of the
isolated C-terminal nuclease domain of EcoPrrC had no
effect on cell growth, even when the nuclease domain was
expressed from a multicopy 2m plasmid (data not shown).
In addition, we found that induced coexpression of the
EcoPrrC NTPase and nuclease domains in trans (from
separate genes on CEN or 2m plasmids) also had no
effect on yeast growth (data not shown). We surmised
from these results that the NTPase and nuclease
domains must be linked in cis for EcoPrrC to exert its
toxicity in yeast.
A plausible direct activation model invokes
NTP-triggered dimerization of the NTPase domain to
yield a PrrC quaternary structure in which the previously
latent nuclease module is now functional for tRNA target
recognition and scission. One prediction of an obligatory
oligomerization model is that overexpression of inactive
Figure 4. Rescue of EcoPrrC S217 and C386A toxicity by 2m
tRNA
Lys(UUU).( A) Serial dilutions of wild-type yeast cells bearing a
CEN plasmid encoding galactose-regulated EcoPrrC mutants S217A or
C386A plus a 2m plasmid carrying the indicated yeast tRNA genes (or
an empty 2m vector, denoted by a dash) were spotted on –Leu–Ura
agar plates containing glucose or galactose. (B) Serial dilutions of yeast
trm9 cells bearing a CEN plasmid encoding galactose-regulated
wild-type EcoPrrC or mutants S217A or C386A plus a 2m plasmid
carrying the indicated yeast tRNA genes (or an empty 2m vector,
denoted by a dash) were spotted on agar plates containing glucose or
galactose. (C) Serial dilutions of yeast tot3 cells bearing a CEN
plasmid encoding galactose-regulated wild-type EcoPrrC or mutants
S217A or C386A plus a 2m plasmid carrying the indicated yeast
tRNA genes (or an empty 2m vector, denoted by a dash) were
spotted on agar plates containing glucose or galactose.
696 Nucleic Acids Research, 2011,Vol. 39,No. 2mutants of PrrC might dampen the activity of wild-type
PrrC, by forcing the assembly of defective
hetero-oligomers via mass action. We evaluated this
scenario by installing several of our nontoxic prrC-Ala
alleles on 2m plasmids under the control of a GAL1
promoter. After verifying that these mutants were
nontoxic when the 2m plasmid-bearing cells were plated
on galactose-containing agar (Figure 5A; PrrC–), we
tested them for a dominant-negative effect on the
galactose-induced growth arrest caused by wild-type
EcoPrrC on a CEN plasmid (Figure 5A; PrrC+).
Spotting tests revealed distinct levels of effects exerted
by overexpression of the mutants in trans. For example,
mutants K46A, T250A and H251A in the NTPase domain
partially suppressed the toxicity of wild-type EcoPrrC and
allowed the cells to form colonies on galactose agar, albeit
smaller colonies than the ‘PrrC–’ controls (Figure 5A). In
contrast, mutants H315A, R320A and E324A in the
nuclease domain had essentially no impact on the
toxicity of wild-type EcoPrrC (Figure 5A).
To quantify the dominant negative effect, we grew
liquid cultures of yeast strains bearing a CEN wild-type
EcoPrrC plasmid (or empty CEN control) plus 2m
plasmids expressing 15 different nontoxic PrrC-Ala
mutants (or an empty 2m vector control). Equal aliquots
of cells from the cultures were then transferred to liquid
medium containing galactose to induce PrrC expression.
Measurement of A600 after overnight growth in galactose
± wild-type EcoPrrC revealed that the PrrC–culture
bearing the empty 2m vector had grown to saturation
(A600 > 4.0), while the PrrC+ culture was arrested
completely (A600 0.26; compare black and white bars in
Figure 5B, ‘vector’). Six of the PrrC mutants (H295A,
H315A, R320A, E324A, R349A and H356A) had little
or no impact on the toxicity of wild-type PrrC, i.e. cells
expressing these mutant alone grew to saturation in
galactose (A600 > 4.0), whereas cells coexpressing
wild-type PrrC grew to A600 of 0.3–0.6 (Figure 5). In
contrast, the toxicity of wild-type PrrC was clearly
ameliorated in cells overexpressing mutants K46A,
T47A, R48A, K168A, D215A, D216A, S220A, T250A
and H251A, such that the cultures grew to A600 values
of 1–2 (Figure 5B). It was most striking that all of the
dominant negative mutations were in the putative
active-site motifs of the NTPase domain, whereas the mu-
tations that did not have a negative effect in trans were all
in located in the nuclease domain.
These results are consistent with a model for the
physical organization of the active EcoPrrC toxin, in
which: (i) antiparallel head-to-tail dimerization of the
NTPase domain is required for PrrC toxicity in yeast;
and (ii) toxicity requires two fully functional
NTP-binding phosphohydrolase active sites (Figure 6A).
Consequently, the dominant negative effect of the NTPase
mutants results from the formation of mixed dimers in
which one of the active sites is defective (Figure 6B). In
contrast, we infer that just one active nuclease module
sufﬁces for PrrC toxicity in yeast, provided that proper
dimerization has occurred, thereby accounting for why
overexpression of PrrC with a nuclease-inactivating
mutation (but an intact NTPase domain) does not
diminish the toxicity of wild-type EcoPrrC (Figure 6C).
(A caveat to this interpretation of the absence of
dominant negative effects of the nuclease mutants is that
we have not directly gauged the steady-state levels of the
mutant PrrC proteins expressed in yeast from the 2m
plasmids. Thus we cannot exclude a scenario in which
all of the mutations surveyed in the nuclease domain
destabilize PrrC in yeast while none of the mutations
in the NTPase domain have this effect.) The model in
Figure 6 focuses on dimerization as a key quaternary-
structure trigger, but is equally adaptable to alternative
Figure 5. Dominant negative effects of PrrC-Ala mutants. (A) Serial dilutions of yeast cells bearing a CEN plasmid encoding wild-type
EcoPrrC (PrrC+) or the empty CEN vector (PrrC–) plus a 2m plasmid encoding the indicated PrrC-Ala mutants (or the empty 2m vector) were
spotted on –Leu–His agar plates containing glucose or galactose. (B) Yeast cells bearing a CEN plasmid encoding wild-type EcoPrrC (PrrC+) or the
empty CEN vector (PrrC–) plus a 2m plasmid encoding the indicated PrrC-Ala mutants (or the empty 2m vector) were inoculated into SD–Leu–His
medium containing 2% galactose to attain an A600 of 0.1. The cultures were incubated at 30 C for 18h, at which time A600 was measured. Each
datum is the average of three independent galactose-induction experiments ±SEM.
Nucleic AcidsResearch, 2011, Vol.39,No. 2 697oligomerization models, variously invoking hexameric or
tetrameric states of EcoPrrC (18,19,33), wherein all
NTPase sites, but not necessarily all nuclease sites, must
be intact to exert toxicity.
CONCLUSIONS
Programmed RNA damage is a common feature of
cellular responses to virus infection, whether it be tRNA
restriction by PrrC in E. coli (14) or innate immune sig-
naling via RNase L-damaged RNAs in mammalian cells
(42). There is also a growing consensus that programmed
RNA damage—especially tRNA damage—is a common
feature of eukaryal cellular stress responses, wherein the
broken tRNAs molecules per se can have a signaling role
at levels of tRNA damage that do not signiﬁcantly deplete
the pool of the tRNA target (43–51). This suggests a
possible therapeutic niche for enzymatic and chemical
ribotoxins, predicated either on: (i) depleting an essential
RNA or (ii) eliciting an ‘RNA damage response’ (e.g.
reduced and altered protein synthesis, altered gene expres-
sion, cell-cycle arrest, apoptosis, etc.) analogous to DNA
damage responses. As an example of the former mode,
Kaufmann et al. have suggested PrrC as a means of inter-
dicting HIV infection via depletion of the pool of human
tRNA
Lys that serves as primer for HIV reverse transcript-
ase (17,52).
Cytotoxic ribonucleases from bacteria and eukarya ex-
emplify a new modality of cancer therapy (53). Onconase,
an RNase A-like ribonuclease elaborated by frogs, has
been studied extensively as an anticancer agent (54).
Onconase cytoxicity is facilitated by its ready uptake by
mammalian cells, its resistance to the cellular RNase in-
hibitor protein and its induction of damage to tRNAs in
human tumor cells (55). Bacterial tRNA ribotoxins have
much higher selectivity for speciﬁc tRNA target sites than
does Onconase. The present demonstration that PrrC is
fungicidal in yeast, together with recent reports that
colicins D and E5 are also growth suppressive in yeast
(22,23), suggest practical applications for bacterial
tRNA anticodon nucleases in eukarya. Because fungi
appear not to have an endogenous RNA repair system
capable of rectifying the tRNA anticodon breaks (56),
they would be vulnerable to ribotoxins as antifungals,
provided one could devise a way to modify the toxin to
promote its cellular uptake. Cancer cells might also be
sensitized to tRNA ribotoxins, alone or in combination
with other chemotherapeutics.
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